Mitral Doppler as a Predictor of Respiratory Worsening After Vascular Filling
EVALDM
Assessment of Mitral Doppler as a Predictor of Respiratory Worsening After Vascular Filling for ICU Patients With Mechanical Ventilation. The EVALDM Study
1 other identifier
interventional
200
1 country
3
Brief Summary
Interventional study of the accuracy of a non-invasive testing by echocardiography to predict respiratory worsening after vascular filling.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2018
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 30, 2018
CompletedFirst Submitted
Initial submission to the registry
February 2, 2018
CompletedFirst Posted
Study publicly available on registry
February 27, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2023
CompletedSeptember 22, 2021
September 1, 2021
4.9 years
February 2, 2018
September 21, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
frequency of the occuring of premature degradation respiratory
definied by a reduction of at least 15% of the SpO2/FiO2 ratio in the 30min following the vascular filling
30 minutes after vascular filling
Study Arms (1)
Mitral doppler
EXPERIMENTALMitral doppler before and after vascular filling
Interventions
Eligibility Criteria
You may qualify if:
- Mechanical ventilation
- And hemodynamic failure
- And decision of the attending physician to perform a vascular filling
You may not qualify if:
- Pregnancy and breast-feeding women
- Patients deprived of their administrative or judicial freedom
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Ch Bourg En Bresse
Bourg-en-Bresse, France
Centre Hospitalier Metropole Savoie
Chambéry, 73000, France
CHU Grenoble Alpes
La Tronche, 38700, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 2, 2018
First Posted
February 27, 2018
Study Start
January 30, 2018
Primary Completion
January 1, 2023
Study Completion
February 1, 2023
Last Updated
September 22, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share